Answers are grounded in this paper and cite their sources.
Evaluates antioxidant and anticancer effects of Tabernaemontana divaricata extracts, indicating potential for ovarian cancer treatment.
Ovarian cancer is one of the most serious gynecological cancers and remains a significant cause of cancer-related deaths among women worldwide. The limitations associated with conventional therapies, including side effects and drug resistance, have increased interest in plant-derived compounds as alternative therapeutic agents. In the current research, the antioxidant, anti-inflammatory, cytotoxic, and anticancer activities of Tabernaemontana divaricata plant extracts were assessed using in vitro models. The antioxidant potential of the extracts was assessed through free radical scavenging assays, while anti-inflammatory activity was resolved using the protein denaturation inhibition method. Cytotoxicity studies were conducted on normal L929 fibroblast cell lines to assess the biocompatibility of the extracts. The anticancer activity against the human ovarian cancer cell line SKOV3 was evaluated using the MTT assay at different concentrations of the plant extracts. The study findings revealed that the extracts exhibited appreciable antioxidant activity by effectively neutralizing free radicals in a dose-dependent manner. Remarkable anti-inflammatory activity was also observed through the inhibition of protein denaturation. Cytotoxicity analysis indicates minimal toxicity to L929 normal cell lines, suggesting relative safety toward non-cancerous cells. In contrast, treatment of SKOV3 ovarian cancer cells with the extracts resulted in a substantial reduction in cell viability, indicating strong anticancer potential. Overall, the outcome indicates that Tabernaemontana divaricata possesses promising bioactive properties with potential therapeutic relevance for ovarian cancer. The study supports the potential use of this medicinal plant as a natural source for developing safer, more effective anticancer agents, warranting further molecular and in vivo investigations.
No takes yet. Share an insight, caveat, or question.
Katepogu et al. (2026) studied this question.